Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valsartan/Amlodipine vs Losartan/Amlodipine in Moderate Hypertension
NCT00716950Phase 4Unknown
- Sponsor
- University of Pavia
- Start
- Jul 2008
- Primary completion
- Feb 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of valsartan in essential hypertension (2 arms), sponsored by University of Pavia. Primary endpoint: 24 hours mean diastolic blood pressure at 4 weeks. Status: unknown.
02
Drugs
valsartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00716950.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00716950.